Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1993-12-09
1996-07-02
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514141, 558214, 558217, 564 15, 546 22, 546 23, 544 57, 544157, 544337, C07F 902, C07F 928, C07D27912, A61K 3166
Patent
active
055322263
ABSTRACT:
Novel benzylphosphonate compounds of the general formula I: ##STR1## are disclosed as useful in treating bone wasting diseases including postmenopausal osteoporosis in increasing in mammals bone formation and bone mass.
REFERENCES:
patent: 2917533 (1959-12-01), Burger et al.
patent: 3363032 (1968-01-01), Fitch
patent: 4610807 (1986-09-01), Brinkwert et al.
patent: 5242908 (1993-09-01), Peyman et al.
patent: 5300687 (1994-04-01), Schwender et al.
R. Hermant, et al., Systematic Study of a Series of Highly Fluorescent Rod-Shaped Donor-Acceptor Systems, J. Am. Chem. Soc. 1990, 112, 1214-1221.
Hermant et al., J. Am. Chem. Soc. (1990) 112, 1214-1221.
Terada et al, Chem. Abs. (1990) 112:235,189 p.
Brinkwerth, Chem. Abs. (1986) 104: 35,465y.
Demarest Keith
Schwender Charles
Wustrow David
Grumbling Matthew V.
Ortho Pharmaceutical Corporation
Palo Ralph R.
LandOfFree
Trifluoromethybenzylphosphonates useful in treating osteoporosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trifluoromethybenzylphosphonates useful in treating osteoporosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trifluoromethybenzylphosphonates useful in treating osteoporosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1506474